Copy Link Print Information

Pertuzumab (anti-HER2)

10 Cited Publications
Customer Review

Based on 10 publication(s) in Google Scholar

Pertuzumab (anti-HER2), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.

For research use only. We do not sell to patients.

  • Purity: 99.10%
  • CAS No.: 380610-27-5
  • Molecular Weight:144 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Pertuzumab (anti-HER2)
  • Experimental Validation Results for Pertuzumab (anti-HER2)
  • Experimental Validation Results for Pertuzumab (anti-HER2)
  • Experimental Validation Results for Pertuzumab (anti-HER2)
  • Pertuzumab (anti-HER2) Chemical Structure
    Pertuzumab (anti-HER2) Chemical Structure
CAS No.: 380610-27-5
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Pertuzumab (anti-HER2):

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Pertuzumab (anti-HER2)

More
Customer Validation & Images
In Vivo Imaging
  • In Vivo Imaging

All EGFR Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Human Her2/ERBB2 Protein (ECD, His Tag) can bind Pertuzumab (anti-HER2). The EC50 for this effect is 12.73 μg/mL.

  • 1/16

    Pertuzumab has a significant ADCC effect on SK-BR-3 cells in a dose-dependent manner.The EC50 for this effect is 61.54 and 74.56 ng/mL.

  • 1/16

    Pertuzumab (anti-HER2) purchased from MedChemExpress. Usage Cited in: Sci Rep. 2024 Feb 14;14(1):3771. [Abstract]

    Customer Validation
     In vivo probing of HER2 and EGFR in FADU tumors with immune-PET imaging. FADU tumors were injected and imaged with [89Zr]-pertuzumab PET imaging. Pertuzumab (10 mg/mL) was conjugated with 0.4 mg deferoxamine (DFO). DFO–pertuzumab was labeled with [⁸⁹Zr] at 6 µCi/µg, and approximately 66.8 ± 15 µCi [⁸⁹Zr]‑pertuzumab (n = 6) was injected intravenously. Approximately 10–12 µg of radiolabeled antibody was administered before imaging.

  • Pertuzumab (anti-HER2) Chemical Structure
    1/16
  • Pertuzumab (anti-HER2)
  • Immobilized Human Her2/ERBB2 Protein (ECD, His Tag) can bind Pertuzumab (anti-HER2). The EC50 for this effect is 12.73 μg/mL.
  • Pertuzumab has a significant ADCC effect on SK-BR-3 cells in a dose-dependent manner.The EC50 for this effect is 61.54 and 74.56 ng/mL.